Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | BMI | WSBC |
|---|---|---|
| Price | $124.89 | $37.75 |
| Change today | ▼ 2.25% | ▼ 0.94% |
| Market cap | $3.62B | $3.62B |
| Return, 3 months | -14.8% | -3.1% |
| Return, year to date | -27.7% | +17.2% |
| Return, 1 year | -30.2% | +17.8% |
| P/E (TTM) | 29.2 | 10.7 |
| P/B | 5.3 | 0.9 |
| P/E percentile vs own 5y | 3rd | – |
| Dividend yield | 1.28% | 4.00% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | +24.0% | +14.6% |
| Analyst buy share | 67% | 50% |
| RSI (14) | 42 | 37 |
| 30-day volatility | 29.5% | 17.6% |
| Max drawdown, 1 year | -39.3% | -12.9% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
